NHI outlines $4.68-$4.70 2026 NFFO guidance while targeting high single-digit to low double-digit organic SHOP NOI growth (NYSE:NHI)
National Health Investors (NHI) provided 2026 NFFO guidance of $4.68-$4.70 and aims for high single-digit to low double-digit organic SHOP NOI growth. CEO D. Mendelsohn announced the sale of the NHC portfolio, reducing skilled nursing exposure and increasing investment in private pay senior housing.
How this was made
The 30-second read
Why it matters
The guidance provides the first quantitative outlook for 2026, influencing valuation and investment decisions.
Market read
Guidance may shift NHI's stock price and affect comparable REITs.
What to watch
Potential impact of the recent sale of the NHC portfolio and reduced skilled‑nursing exposure on future cash flows.
Background
National Health Investors (NHI) reported Q3 2026 earnings call highlights, emphasizing portfolio changes and forward guidance.
Ticker impact
NHI disclosed its 2026 NFFO guidance of $4.68‑$4.70 and projected high single‑digit to low double‑digit organic SHOP NOI growth.
potential pressure if guidance is below market expectations; upside if seen as improvement over prior outlook
The new guidance is the first public disclosure of 2026 targets, which can shift valuation models.
Market effects
Sets a benchmark for senior‑housing REITs and may influence peer valuation.
Limited to U.S. REIT market; no broader regional effect.
Low; relevance confined to U.S. healthcare real‑estate investors.
Counterpoint
If investors expect higher NOI growth, the guidance could be viewed as a disappointment.
Key entities
- CompanyNational Health Investors
U.S. REIT focused on senior housing and healthcare properties.
